Answers are grounded in this paper and cite their sources.
In this study, several workflows to analyze human plasma proteins with RP-LC MS/MS are evaluated. The impact of depletion of abundant proteins on the plasma proteome coverage was assessed together with the duration of RP-LC separation. An additional upstream liquid-based fractionation was evaluated. The applicability and feasibility of these technologies in large-scale clinical studies with respect to effort, throughput, and outcome are discussed. Label-free and isobaric tagging-based quantifications are examined in this perspective. We demonstrate that, despite the great improvement of proteomic technologies, significant trade-offs between effort and yield are still challenging the discovery of protein biomarkers in blood plasma.
No takes yet. Share an insight, caveat, or question.
Dayon et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: